Unicentric Form of Castleman Disease - Surgery Therapy Benefit

Charles University, Czech Republic20 enrolled

Overview

Observation study on patients with unicentric form of Castleman disease, evaluation of surgical treatment benefit. Observation of surgical treatment strategy.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Castleman Disease Unicentric Castleman Disease Surgery

Interventions

surgery type/exstirpation/debulkingPROCEDURE

Evaluation of benefit according to surgery

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * patient with unicentric form of Castleman disease * underwent surgery resection Exclusion Criteria: * multilocalised Castleman disease

Outcomes

Primary Outcomes

5 year survival

surgery treatment success

Time frame: each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression

recurence rate

surgery treatment success

Time frame: each 6 months checkup, up to 150 weeks, from date of randomization until the date of first documented progression

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.